Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Bertin Bioreagent
anti-Dihydroergocryptine and its main metabolites, pAb
As low as
579
CHF
CHF 579.00
In stock
Only %1 left
BRT-A03608-T500500 dtnCHF 579.00
NEW
| Product Details | |
|---|---|
| Synonyms | DHEC |
| Product Type | Polyclonal Antibody |
| Properties | |
| Source/Host | Rabbit |
| Immunogen/Antigen | Dihydrolysergic acid-BSA. |
| Application | EIA |
| Formulation | Liquid. In Phosphate Buffer. |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Declaration | Manufactured by Bertin Bioreagent |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Long Term Storage | +4°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Documents | |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Dihydroergocryptine (DHEC) is a dopamine agonist of the ergoline group that is used as an antiparkinson agent in the treatment of Parkinson's disease. Dihydroergocryptine is a mixture of two very similar compounds, alpha- and beta-dihydroergocryptine (epicriptine) at a ratio of 2:1. The major metabolites are Dihydroergocryptinine, 14-Hydroxy-dihydroergocryptine and a few other minor metabolites. These metabolites are excreted mainly in the urine.